SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (7461)4/26/1998 9:52:00 AM
From: Richard Singer  Read Replies (1) of 23519
 
<<Once again, Vivus' management has misled investors and the street and will ultimately be held accountable.>>

I wouldn't argue this point. However, there are about 11 weeks left in Q2, before they have to put up. Most reasonable observers have already plugged lousy numbers for this quarter attributed to Viagra. Scrips should be very disappointing. But the Vivus line,i.e. that the expanded ED market created by their good friend PFE will be a golden lining for VVUS, cannot be disproven for a long,long time.(nor can it be proven)

In the meantime, VVUS has regained headline attention and big-time volatility when many, including me, considered it a dead issue.

Richard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News